Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessie R Nedrow-Byers

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 25, 2011
Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigenTiancheng Liu, Jessie R Nedrow-Byers, Mark R Hopkins, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2012
Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticlesBenjamin B Kasten, Tiancheng Liu, Jessie R Nedrow-Byers, et al.
International Journal of Oncology|February 19, 2011
Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned mediumTiancheng Liu, Mohamed Jabbes, Jessie R Nedrow-Byers, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugateTiancheng Liu, Jessie R Nedrow-Byers, Mark R Hopkins, et al.
The Prostate|August 23, 2012
PSMA-targeted SPECT agents: mode of binding effect on in vitro performanceJessie R Nedrow-Byers, Adam L Moore, Tanushree Ganguly, et al.
The Prostate|June 7, 2012
A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agentJessie R Nedrow-Byers, Mohamed Jabbes, Cayla Jewett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancerSuzanne E Lapi, Hilla Wahnishe, David Pham, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|October 25, 2011
Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigenTiancheng Liu, Jessie R Nedrow-Byers, Mark R Hopkins, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2012
Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticlesBenjamin B Kasten, Tiancheng Liu, Jessie R Nedrow-Byers, et al.
International Journal of Oncology|February 19, 2011
Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned mediumTiancheng Liu, Mohamed Jabbes, Jessie R Nedrow-Byers, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugateTiancheng Liu, Jessie R Nedrow-Byers, Mark R Hopkins, et al.
The Prostate|August 23, 2012
PSMA-targeted SPECT agents: mode of binding effect on in vitro performanceJessie R Nedrow-Byers, Adam L Moore, Tanushree Ganguly, et al.
The Prostate|June 7, 2012
A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agentJessie R Nedrow-Byers, Mohamed Jabbes, Cayla Jewett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancerSuzanne E Lapi, Hilla Wahnishe, David Pham, et al.
Pageof 1